CA19-9
WordNet
- an essential structural component of living cells and source of energy for animals; includes simple sugars with small molecules as well as macromolecular substances; are classified according to the number of monosaccharide groups they contain (同)saccharide, sugar
- any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)
PrepTutorEJDIC
- 炭水化物,含水炭素
- 抗原(生物の体内にはいって免疫体を作る物質)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer.
- Elisei R1, Lorusso L2, Piaggi P2, Torregrossa L2, Pellegrini G2, Molinaro E2, Agate L2, Bottici V2, Pani F2, Cacciato Insilla A2, Casella F2, Ciampi R2, Tognetti I2, Materazzi G2, Basolo F2, Romei C2.
- European journal of endocrinology / European Federation of Endocrine Societies.Eur J Endocrinol.2015 Sep;173(3):297-304. doi: 10.1530/EJE-15-0304. Epub 2015 Jun 1.
- BACKGROUND: Medullary thyroid cancer (MTC) is capable of secreting several proteins, such as calcitonin (Ct), carcinoembryonic antigen (CEA), chromogranin and others. Recently, we observed an aggressive MTC with high levels of serum carbohydrate antigen 19.9 (Ca 19.9) and a rapid evolution to death.
- PMID 26034076
- Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
- Kim JR1, Jang JY1, Kang MJ1, Park T2, Lee SY3, Jung W1, Chang J1, Shin Y1, Han Y1, Kim SW1.
- Journal of hepato-biliary-pancreatic sciences.J Hepatobiliary Pancreat Sci.2015 Sep;22(9):699-707. doi: 10.1002/jhbp.275. Epub 2015 Jul 14.
- BACKGROUND: Little is known about the prognostic significance of serum carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) concentrations for predicting malignancy in patients with intraductal papillary mucinous neoplasm (IPMN) of pancreas.METHOD: The study cohort consisted of 367 pati
- PMID 26178866
- Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
- Han SX1, Zhou X2, Sui X1, He CC1, Cai MJ1, Ma JL1, Zhang YY1, Zhou CY1, Ma CX1, Varela-Ramirez A3, Zhu Q1.
- Oncotarget.Oncotarget.2015 Aug 14;6(23):19907-19917.
- PURPOSE: To identify whether Dickkopf-1 (DKK1) could be a potential biomarker for early detection and prognosis in patients with pancreatic cancer (PC).METHODS: Serum was collected from 140 patients with pancreatic adenocarcinoma and 92 control patients without pancreatic adenocarcinoma. Serological
- PMID 26101916
Japanese Journal
- 惣田 哲次,福本 亮,林 哲也 [他],岡 大三,藤本 宜正,小出 卓生,赤丸 祐介,春日井 務
- 泌尿器科紀要 = Acta urologica Japonica 58(10), 561-564, 2012-10-00
- … He showed high levels of serum carbohydrate antigen 19- 9 (CA19-9) and carcinoembryonic antigen (CEA). … A histopathological diagnosis was papillary adenocarcinoma positive for prostate specific antigen (PSA). … Because the level of serum PSA was 9.39 ng/ml, prostate biopsy was performed and ductal adenocarcinoma of prostate was revealed. …
- NAID 120005026094
- 岩崎 晃太,稲葉 毅,冲永 功太,井上 泰介,小川 越史,堀川 昌宏,小出 泰平,山崎 江里子,今村 哲夫,福島 亮治
- 日本外科系連合学会誌 37(4), 777-783, 2012-08-30
- NAID 10031033382
- Schwannoma of the stomach with elevated preoperative serum carbohydrate antigen 19-9 : report of a case
- FUKUCHI Minoru,NAITOH Hiroshi,SHOJI Hisanori,YAMAGISHI Junko,SUZUKI Masaki,YANOMA Toru,KIRIYAMA Shinsuke,KUWANO Hiroyuki
- Surgery today : the Japanese journal of surgery 42(8), 788-792, 2012-08-01
- NAID 10030949229
Related Links
- Carbohydrate antigen (CA19-9) is a protein that is found in very small amounts on the surface of certain cancer cells. It may be found in the blood when it is shed by tumour cells
- Carbohydrate Antigen (CA) 19-9 blood test is ordered to monitor pancreatic, liver, gastrointestinal, and colorectal malignancies. ... Results: 2-3 business days. Also known as: CA 19-9. The determination of CA 19-9 can't be used for ...
★リンクテーブル★
[★]
- 同
- 糖鎖抗原19-9 carbohydrate antigen 19-9, CA-19-9
- 関
- ルイス式血液型
概念
- 各種の消化器癌や膵癌、胆肝癌の患者に高頻度かつ高濃度に検出される抗原である。
- ヒト大腸癌細胞株SW1116に対して作成された単クローン抗体の認識する糖鎖抗原であり、腫瘍マーカー検査に用いられる。
- 抗原は Gal1-3GlcNAc の繰り返し構造(I型糖鎖)を基本骨格とするルイスA(Lea)の血液型糖鎖にシアル酸が結合したシアリルルイスAである
基準値
分布
- 膵管、胆嚢、胆管、胃、気管支、唾液腺、前立腺、結腸、直腸などの上皮細胞上に分布
意義
婦人科
-
- 癌の血行性転移を促進するらしい
- 正常の胆管膵管上皮、唾液腺でも発現
注意
- 血液型Lea陰性者(日本人の5-10%)では陰性を示す
[★]